Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Global Burden and Strength of Evidence for 88 Risk Factors in 204 Countries and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021
Fatemeh Nabavizadeh Rafsanjani
Fatemeh Nabavizadeh Rafsanjani

Professor of Physiology

Department Physiology

School of Medicine

Electrophysiology Research Center

Tehran University of Medical Sciences

All Documents
1. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
2. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)